Search for: "Doe v. Defendant A et al"
Results 441 - 460
of 4,623
Sort by Relevance
|
Sort by Date
21 Feb 2022, 5:53 pm
But what does the duty require in practice? [read post]
16 Feb 2022, 9:46 am
Lusardi v. [read post]
15 Feb 2022, 2:05 pm
The nature of these suits varies based on the defendants named and whether they are brought before or after the de-SPAC transaction. [read post]
15 Feb 2022, 6:15 am
Gabet et al. v. [read post]
13 Feb 2022, 5:39 pm
The Ontario Superior Court of Justice recently decided this in Parekh et al v. [read post]
10 Feb 2022, 1:44 pm
LS & CX, LLC, et. al., Case No. 4:20-CV-312 (E.D. [read post]
9 Feb 2022, 9:06 am
The defendant does not dispute Dr. [read post]
8 Feb 2022, 9:43 am
The case and decision In Parekh et al v. [read post]
3 Feb 2022, 6:49 pm
Symphony Bronzeville Park, LLC, et al., 2022 IL 126511 (Feb. 3, 2022), holding that claims for statutory damages against an employer under the Illinois Biometric Information Privacy Act (“BIPA”) are not preempted by the exclusivity provisions of the Illinois Workers’ Compensation Act (the “IWCA”). [read post]
26 Jan 2022, 3:20 pm
CCRRG then discontinued defending Capri and disclaimed any further coverage. [read post]
24 Jan 2022, 4:33 pm
" (citations and internal quotations omitted)); see 19 Moore et al., § 205.05, at 205-57 to -58 ("the rule [of waiver] is prudential and may be disregarded as justice requires"). [read post]
24 Jan 2022, 11:03 am
., LLC v. [read post]
21 Jan 2022, 5:41 am
Guardant bases its contentions that Reveal works on “[p]eer reviewed data published by Parikh, et al., in the journal of Cancer Research. [read post]
18 Jan 2022, 10:02 am
The court finds the Doe v. [read post]
18 Jan 2022, 8:10 am
Corson v. [read post]
18 Jan 2022, 4:44 am
This policy was based on Peranzo et al. v. [read post]
14 Jan 2022, 5:18 am
AWGI, LLC et al. v. [read post]
10 Jan 2022, 5:15 am
AWGI LLC et al. v. [read post]
10 Jan 2022, 4:23 am
" Interprofession du Gruyère et al. v. [read post]
9 Jan 2022, 1:45 am
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary form of immunotherapy in which a patient's own T cells are reprogrammed to target harmful (e.g. cancer) cells (Singh et al.). [read post]
